Heart Failure

January 19, 2021

A meta-analysis of nearly 20 studies is offering clinicians further insight into the effects of consuming fried foods on cardiovascular health.

January 12, 2021

A retrospective cohort study suggests peak atrial longitudinal strain and peak atrial contraction strain could help clinicians identify HFpEF patients at greatest risk for developing atrial fibrillation.

January 09, 2021

An analysis of data from a medical center in the UK suggests patients with heart failure were at nearly double the risk of dying from COVID-19 as their counterparts without COVID-19.

January 06, 2021

An analysis of more than 1000 matched pairs of women receiving one of two common treatments for breast cancer were half as likely to be hospitalized for heart failure if they were also using statins.

January 05, 2021

Gregory Weiss, MD, offers perspective on the diagnosis and management of heart failure during 2020.

December 24, 2020

This article features the top 5 stories in Practical Cardiology's coverage of heart failure in 2020.

November 24, 2020

An analysis of data from the Women's Health Initiative details the detrimental impact of sedentary behavior on the risk of heart failure in older women.

November 18, 2020

TRANSLATE-HF is a collaborative effort between the AHA and AstraZeneca with the goal of increasing and optimizing SGLT2 inhibitor use in US patients. Hear further insight lead author from the first of 6 TRANSLATE-HF studies, which was presented at AHA 2020.

November 17, 2020

Deepak Bhatt, MD, MPH, offers his thoughts on the results of SCORED and SOLOIST as well as diving deeper into the implications of the data for sotagliflozin and SGLT2 inhibitors moving forward.

November 17, 2020

Data from the phase 3 SOLOIST-WHF and SCORED trials suggest sotagliflozin was associated with significant reductions in death from CVD in patients with worsening heart failure and significant reductions in blood glucose levels among patients with moderate to severe kidney impairment.

November 15, 2020

An analysis of HFrEF patients from the GWTG-HF registry suggests 81% met eligibility criteria for receiving treatment with dapagliflozin.

November 14, 2020

Professor John McMurray discusses DAPA-CKD and what insights it provides into the cardiorenal protection seen with dapagliflozin (Farxiga) use in the landmark trial.

November 14, 2020

Javed Butler, MD, MPH, discusses the results of a prespecified analysis of EMPEROR-Reduced examining the effect of empagliflozin on KCCQ-CSS and heart failure symptoms.

November 14, 2020

Professor John McMurray offers insight into a discussion he led at AHA 2020 exploring the notion that treatment of men and women with heart failure with preserved ejection fraction should be approached differently.

November 13, 2020

Results of AFFIRM-AHF trial from AHA 2020 detail the effects of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency.

November 11, 2020

George Bakris, MD, discusses an AHA 2020 study that estimated the number of diabetics in the US that were considered eligible for receiving a prescription for an SGLT2 inhibitor.

November 10, 2020

An analysis of the phase 3 EXPLORER-HCM trial offers further insight into the effects of mavacamten in patients with obstructive hypertrophic cardiomyopathy.

November 06, 2020

Practical Cardiology Advisory Board member Dr. Brett Nowlan details his experiences with wearables as a practicing cardiologist.

October 26, 2020

Results of a prospective, non-randomized trial indicate an approach using the HeartMate II LVAD combined with optimized medical therapy could increase the rate of device explantation and help facilitate cardiac remodeling.

October 13, 2020

An analysis of data from the REGARDS study suggests more than half of all patients hospitalized with heart failure were prescribed 10 or more medications at discharge.